Leen Kawas Highlights BioTech Industry Trends
The biotech industries in the United States are undergoing regeneration. According to RBC Capital Markets biotech industry market analysis in February 2023, the sector’s recent shutdowns have been caused by several unproven early-stage IPO names. This has led to clinical trials and regulatory difficulties, however, the industry began to show some significant changes in mid-2022 – with the venture capital market purely focusing on quality...